Mode
Text Size
Log in / Sign up

Oral Squamous Cell Carcinoma

Part of Head and Neck Cancer

25 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Oral Squamous Cell Carcinoma

4 trials tracked for Oral Squamous Cell Carcinoma: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 29 citations.

4Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 2 Phase 1 1
  1. Phase 3 Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma Completed · 29 cited
  2. Phase 2 Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma Completed
  3. Phase 2 Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma Completed
  4. Phase 1 Neoadjuvant Imiquimod Immunotherapy for Oral Cancer Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Head and Neck Cancer

Related studies from across the Head and Neck Cancer family.

Post-operative ctDNA linked to worse survival in HPV-negative HNSCC, but estimate unstable
Oncology Meta-analysis
Post-operative ctDNA linked to worse survival in HPV-negative HNSCC, but estimate unstable ctDNA levels may signal cancer return in head and neck cancer
This meta-analysis examined post-operative ctDNA as a prognostic marker in HPV-negative head and neck squamous cell carcinoma. Detectable ct…
Detecting traces of cancer DNA in the blood after surgery may help identify patients at higher risk of cancer returning.
Cisplatin Chemoradiotherapy for Elderly Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ENT (Otolaryngology) RCT
Cisplatin Chemoradiotherapy for Elderly Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck New trial tests chemotherapy for elderly patients with head cancer
This trial protocol describes a study evaluating the use of weekly cisplatin in elderly patients with locally advanced squamous cell carcino…
A new trial aims to see if adding a specific chemotherapy drug helps elderly patients with advanced head and neck cancer.
Retropharyngeal lymph node involvement in oropharyngeal squamous cell carcinoma occurs in 11% to 16% of patients
ENT (Otolaryngology) Meta-analysis
Retropharyngeal lymph node involvement in oropharyngeal squamous cell carcinoma occurs in 11% to 16% of patients Retropharyngeal lymph node involvement impacts staging for throat cancer
This meta-analysis of 8,887 patients with oropharyngeal squamous cell carcinoma (OPSCC) identified a pooled prevalence of retropharyngeal ly…
New data shows that certain lymph nodes in the throat area are more likely to spread cancer in specific types of throat cancer cases.
Response-adapted surgery after neoadjuvant immune checkpoint inhibitors improves pathologic complete response in mucosal HNSCC
ENT (Otolaryngology) Meta-analysis
Response-adapted surgery after neoadjuvant immune checkpoint inhibitors improves pathologic complete response in mucosal HNSCC Response-Adapted Surgery May Help Preserve Organs in Head Cancer
This meta-analysis of patients with resectable mucosal head and neck squamous cell carcinoma (HNSCC) found that response-adapted surgery (RA…
A new approach to surgery after immunotherapy may help patients with head and neck cancer keep more of their natural tissue and function.
Smoking history linked to worse survival in HPV-positive oropharyngeal cancer after TORS
Infectious Disease Meta-analysis
Smoking history linked to worse survival in HPV-positive oropharyngeal cancer after TORS Smoking History Linked to Worse Survival in Throat Cancer
In HPV-associated oropharyngeal cancer treated with transoral robotic surgery, smoking history was tied to worse overall survival, though re…
A history of smoking is linked to a higher risk of death for patients with certain types of throat cancer treated with robotic surgery.
Evaluating Dose Escalation to 60 Gy in Locally Advanced Esophageal Squamous Cell Carcinoma
Drug Pipeline RCT
Evaluating Dose Escalation to 60 Gy in Locally Advanced Esophageal Squamous Cell Carcinoma Trial shows higher radiation dose does not improve cancer survival
A Phase 3 trial compares 60 Gy versus 50 Gy of radiotherapy with concurrent chemotherapy for patients with unresectable esophageal squamous …
A large trial shows that increasing radiation doses for advanced esophageal cancer does not improve survival but may increase side effects.
Weekly Cisplatin Regimen Shows Noninferiority to Standard Dosing in Head and Neck Cancer
Oncology RCT
Weekly Cisplatin Regimen Shows Noninferiority to Standard Dosing in Head and Neck Cancer Weekly cisplatin treatment shows promise for head and neck cancer
A randomized trial confirms that weekly cisplatin dosing achieves noninferiority in overall survival for high-risk squamous cell carcinoma p…
A new trial shows that giving chemotherapy weekly instead of every three weeks may offer a comparable survival rate for head and neck cancer…
Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathways
Drug Pipeline Sys. Review
Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathways Plant extracts may slow growth of head and neck cancer
This systematic review examines the effects of plant extracts, including resveratrol, curcumin, quercetin, and anthocyanins, on head and nec…
Certain plant compounds like curcumin and resveratrol show promise in stopping cancer cell growth and resisting chemotherapy in lab studies.
Cetuximab-based regimens achieve 47% objective response rate in HNSCC after immune checkpoint inhibitor failure
ENT (Otolaryngology) Meta-analysis
Cetuximab-based regimens achieve 47% objective response rate in HNSCC after immune checkpoint inhibitor failure Cetuximab shows activity for head and neck cancer patients
This meta-analysis evaluates cetuximab-based regimens for patients with recurrent or metastatic head and neck squamous cell carcinoma follow…
New data shows cetuximab-based treatments provide meaningful results for head and neck cancer patients after other treatments fail.
Immune cell-based therapy shows no significant benefits for tumor response or survival in HNSCC trials
ENT (Otolaryngology) Meta-analysis
Immune cell-based therapy shows no significant benefits for tumor response or survival in HNSCC trials Immune cell therapy shows limited promise for head and neck cancer
This meta-analysis of 30 trials involving 953 patients evaluated immune cell-based therapy (ICT) for head and neck squamous cell carcinoma. …
New data on immune cell-based therapies for head and neck cancer shows mixed results and a need for more rigorous testing.
Perioperative and postoperative immunotherapy timing determines clinical outcomes in locally advanced head and neck squamous cell carcinoma
Allergy & Immunology Sys. Review
Perioperative and postoperative immunotherapy timing determines clinical outcomes in locally advanced head and neck squamous cell carcinoma Timing of immunotherapy affects outcomes for head and neck cancer
This narrative review examines the impact of immunotherapy sequencing on patients with locally advanced head and neck squamous cell carcinom…
The timing of immunotherapy treatment significantly changes how well it controls local and distant spread in head and neck cancer.
HPV16 constitutes 92.5% of single infections in oropharyngeal squamous cell carcinoma cases
Infectious Disease Meta-analysis
HPV16 constitutes 92.5% of single infections in oropharyngeal squamous cell carcinoma cases HPV16 Remains the Most Common Type in Throat Cancer
This meta-analysis of 183 studies involving 17,443 patients identifies HPV16 as the predominant genotype in oropharyngeal squamous cell carc…
A large global study of over 17,000 cases shows that HPV16 is the primary driver of most HPV-related throat cancers.

Questions about Oral Squamous Cell Carcinoma

Are there new treatments that target cell death to help oral squamous cell carcinoma?

Yes, new treatments targeting cell death pathways like ferroptosis, cuproptosis, and autophagy are being studied for oral squamous cell carcinoma, with some showing promise in early research.

Full answer →
Can bacteria in my mouth change as my oral squamous cell carcinoma gets worse?

Yes, research shows that the oral microbiome, including bacteria like Veillonella, shifts as OSCC progresses, with different patterns in early vs. advanced stages.

Full answer →
Does a specific blood test score predict my survival time after oral squamous cell carcinoma?

Yes, blood test scores like COP-MPV, mGPS, NLR, and PLR are linked to survival in OSCC, but they are not precise enough to predict individual survival time.

Full answer →

All Oral Squamous Cell Carcinoma Articles